BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30844549)

  • 1. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity.
    Meng X; Zhou HY; Shen HH; Lufumpa E; Li XM; Guo B; Li BZ
    Autoimmun Rev; 2019 May; 18(5):455-475. PubMed ID: 30844549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the gut microbiome in systemic inflammatory disease.
    Clemente JC; Manasson J; Scher JU
    BMJ; 2018 Jan; 360():j5145. PubMed ID: 29311119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial modulation of the gut microbiome for treating autoimmune diseases.
    Balakrishnan B; Taneja V
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):985-996. PubMed ID: 30146910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in autoimmunity: potential for clinical applications.
    Kim D; Yoo SA; Kim WU
    Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the gut microbiome in cardiovascular and autoimmune diseases.
    Weis M
    Clin Sci (Lond); 2018 Nov; 132(22):2387-2389. PubMed ID: 30455339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging diet to engineer the gut microbiome.
    Wolter M; Grant ET; Boudaud M; Steimle A; Pereira GV; Martens EC; Desai MS
    Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):885-902. PubMed ID: 34580480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Microbiome and Antibiotics in Autoimmune Diseases.
    Vangoitsenhoven R; Cresci GAM
    Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastro-intestinal tract: The leading role of mucosal immunity.
    Steinert A; Radulovic K; Niess J
    Swiss Med Wkly; 2016; 146():w14293. PubMed ID: 27045424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.
    Langan D; Kim EY; Moudgil KD
    Cell Immunol; 2019 May; 339():59-67. PubMed ID: 30638679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human-microbiome superorganism and its modulation to restore health.
    Salvucci E
    Int J Food Sci Nutr; 2019 Nov; 70(7):781-795. PubMed ID: 30843443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbiome in autoimmune diseases.
    De Luca F; Shoenfeld Y
    Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.
    Abdollahi-Roodsaz S; Abramson SB; Scher JU
    Nat Rev Rheumatol; 2016 Aug; 12(8):446-55. PubMed ID: 27256713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The microbiome and autoimmunity].
    Schröder T; Ibrahim S
    Internist (Berl); 2017 May; 58(5):449-455. PubMed ID: 28321459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome.
    Markowiak-Kopeć P; Śliżewska K
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
    Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.